The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Signature Orthopaedics sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Signature Orthopaedics Pty Ltd (Signature Orthopaedics) is a medical device company that develops, manufactures and orthopedic devices. The company offers hip and knee joint replacements, spinal implants, distal extremities, soft tissue repair implants, soft tissue fixation system, cementless stem, modular cup system, and custom devices. Its distal extremities include screws, staples and osteosynthesis implants used for trauma, fusion or to correct deformities. Signature Orthopaedics sells its products globally. The company has operations in Australia, the UK and Ireland, France, and the US. Signature Orthopaedics is headquartered in Sydney, New South Wales, Australia.
The key metrics of Signature Orthopaedics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Signature Orthopaedics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Signature Orthopaedics.
For a detailed understanding of the performance of Signature Orthopaedics, buy the report here.